A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) C07K 16/22 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2611433
Use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA, in particular capable of blocking the biological activity of TrkA, for the preparation of a medicament for treating and/or preventing chronic pain.
L'invention concerne l'utilisation d'un anticorps anti-TrkA capable d'inhiber la liaison entre NGF et TrkA, capable notamment de bloquer l'activité biologique de TrkA, dans la préparation d'un médicament permettant de traiter et/ou de prévenir des douleurs chroniques.
Cattaneo Antonino
Marinelli Sara
Pavone Flaminia
Ugolini Gabriele
Lay Line Genomics S.p.a.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Novel analgesic treatment with prolonged effect does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel analgesic treatment with prolonged effect, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel analgesic treatment with prolonged effect will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1441594